Inventor · disambiguated record
Samuel Rahbar
Also filed as: RAHBAR SAMUEL
17 granted patents·3 pending applications·173 citations·filing 1991–2021
93Inventor score
Top patents by PatentIndex Score
20 records- 0190US6337350B1Inhibitors of formation of advanced glycation endproducts (AGEs)HOPE CITY·Filed 2000·Granted Jan 8, 2002·47 cites·22 claims
- 0286US6589944B1Breakers of advanced glycation endproductsHOPE CITY·Filed 2000·Granted Jul 8, 2003·28 cites·4 claims
- 0384US7652037B2Methods of lowering lipid levels in a mammalHOPE CITY·Filed 2007·Granted Jan 26, 2010·8 cites·8 claims
- 0484US6605642B2Inhibitors of formation of advanced glycation endproducts (AGES)HOPE CITY·Filed 2001·Granted Aug 12, 2003·23 cites·7 claims
- 0581US6693106B2Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)HOPE CITY·Filed 2002·Granted Feb 17, 2004·15 cites·2 claims
- 0681US5268500ACompound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregationMONTEFIORE MED CENTER·Filed 1991·Granted Dec 7, 1993·20 cites·13 claims
- 0780US6787566B2Breakers of advanced glycation endproductsHOPE CITY·Filed 2001·Granted Sep 7, 2004·14 cites·12 claims
- 0877US7320988B2Methods of lowering lipid levels in a mammalHOPE CITY·Filed 2004·Granted Jan 22, 2008·10 cites·1 claims
- 0975US7030133B2Inhibitors of formation of advanced glycation endproducts (AGEs)HOPE CITY·Filed 2003·Granted Apr 18, 2006·8 cites·7 claims
- 1061US11266618B2Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdGHOPE CITY·Filed 2017·Granted Mar 8, 2022·0 cites·10 claims
- 1161US9855233B2Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdGHOPE CITY·Filed 2014·Granted Jan 2, 2018·0 cites·3 claims
- 1259US11583509B2Compound for treating cancer and diabetesHOPE CITY·Filed 2017·Granted Feb 21, 2023·0 cites·12 claims
- 1359US2022331273A1Methods of quantifying n2-(1-carboxyethyl)-2'-deoxy-guanosine (cedg) and synthesis of oligonucleotides containing cedgHOPE CITY·Filed 2021·Application pending·0 cites
- 1458US8580854B2Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitorsRAHBAR SAMUEL·Filed 2006·Granted Nov 12, 2013·0 cites·1 claims
- 1557US2010102218A1METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdGRAHBAR SAMUEL·Filed 2009·Application pending·0 cites
- 1656US9808434B2Compound for treating cancer and diabetesHOPE CITY·Filed 2016·Granted Nov 7, 2017·0 cites·16 claims
- 1754US10029991B2Modulators of development of adipocyte and cancer cellsHOPE CITY·Filed 2013·Granted Jul 24, 2018·0 cites·6 claims
- 1853US2012071559A1METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdGRAHBAR SAMUEL·Filed 2011·Application pending·0 cites
- 1951US8124655B2Use of LR-90 and LR-102 to overcome insulin resistanceRAHBAR SAMUEL·Filed 2008·Granted Feb 28, 2012·0 cites·7 claims
- 2048US11179361B2Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdGHOPE CITY·Filed 2018·Granted Nov 23, 2021·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →